KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 3 filers reported holding KALA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,000 | -28.0% | 82,452 | 0.0% | 0.00% | – |
| Q2 2022 | $25,000 | -95.5% | 82,452 | -79.5% | 0.00% | – |
| Q1 2022 | $556,000 | +2.4% | 402,304 | -10.4% | 0.00% | – |
| Q4 2021 | $543,000 | -59.3% | 448,896 | -11.7% | 0.00% | – |
| Q3 2021 | $1,333,000 | -48.7% | 508,607 | +3.8% | 0.00% | – |
| Q2 2021 | $2,598,000 | -14.3% | 490,088 | +9.0% | 0.00% | -100.0% |
| Q1 2021 | $3,030,000 | -7.2% | 449,466 | -6.6% | 0.00% | 0.0% |
| Q4 2020 | $3,264,000 | -10.9% | 481,480 | -1.5% | 0.00% | 0.0% |
| Q3 2020 | $3,665,000 | -35.2% | 488,582 | -9.2% | 0.00% | 0.0% |
| Q2 2020 | $5,657,000 | +126.9% | 538,300 | +89.8% | 0.00% | 0.0% |
| Q1 2020 | $2,493,000 | +187.2% | 283,593 | +20.5% | 0.00% | – |
| Q4 2019 | $868,000 | -6.1% | 235,368 | -3.1% | 0.00% | – |
| Q3 2019 | $924,000 | -27.0% | 242,927 | +22.5% | 0.00% | – |
| Q2 2019 | $1,265,000 | -19.1% | 198,260 | +4.9% | 0.00% | – |
| Q1 2019 | $1,564,000 | +69.1% | 189,077 | +0.0% | 0.00% | – |
| Q4 2018 | $925,000 | -28.4% | 188,995 | +44.3% | 0.00% | – |
| Q3 2018 | $1,292,000 | -18.5% | 130,965 | +13.5% | 0.00% | – |
| Q2 2018 | $1,585,000 | -24.7% | 115,396 | -13.2% | 0.00% | -100.0% |
| Q1 2018 | $2,106,000 | +56.0% | 133,004 | +82.2% | 0.00% | – |
| Q4 2017 | $1,350,000 | -27.9% | 73,004 | -10.9% | 0.00% | – |
| Q3 2017 | $1,872,000 | – | 81,965 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,333,333 | $5,073,000 | 100.00% |
| CAXTON CORP | 1,483,343 | $5,644,000 | 6.36% |
| Polaris Venture Management Co. V, L.L.C. | 1,197,032 | $4,555,000 | 2.59% |
| RA Capital Management | 4,537,478 | $17,265,000 | 1.03% |
| Orbimed Advisors | 3,447,840 | $13,119,000 | 0.25% |
| Matisse Capital | 46,500 | $177,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 332,831 | $1,266,000 | 0.22% |
| Sofinnova Investments, Inc. | 478,206 | $1,819,000 | 0.16% |
| HARBOURVEST PARTNERS LLC | 99,186 | $377,000 | 0.16% |
| ALGERT GLOBAL LLC | 47,195 | $180,000 | 0.07% |